摘要
临床层面的患者参与是指患者个体参与临床治疗方案或与疾病管理密切相关的其他临床决策,全民层面的公众参与则是指公众通过委员会、公众代表等形式参与卫生政策的制定、通过及实施。基于理论分析和国际实践经验分别对我国两个层面卫生决策体系所面临的主要挑战进行分析,并在此基础上提出倡导和构建我国以患者为中心卫生决策体系的新构想。
Patient participation at the clinical level refers to patients’individual participation in clinical treatment programs or other clinical decisions closely related to disease management,while public participation at the national level refers to public participation in the formulation,adoption and implementation of health policies through committees and public representatives.Based on the theoretical and international practice experience analysis,it analyzes the main challenges faced by the two levels of the health decision-making system in China.On this basis,a new idea of advocating and constructing a patient-centered health decision-making system in China is put forward.
作者
吕兰婷
傅金澜
王汐
LüLan-ting;FU Jin-lan;WANG-Xi(School of Public Administration and Policy,Renmin University of China,Beijing,100872,China;不详)
出处
《中国医院管理》
北大核心
2021年第12期41-46,共6页
Chinese Hospital Management
基金
中国人民大学公共健康与疾病预防控制交叉学科重大创新平台建设成果。
关键词
以患者为中心
卫生决策体系
患者参与
公众参与
patient-centered
health decision system
patient participation
public participation